STOCKS TELEGRAPH

Tag: ELAN

  • Crypto Weekly Winners and Losers

    Crypto Weekly Winners and Losers

    Top Weekly Crypto Gainers

    Despite the volatility seen, which broke the upward momentum of top crypto names such as Bitcoin and Ethereum, a number of cryptocurrencies have performed quite impressively. Several names undertook epic climbs, despite the fateful weekend that triggered a bearish market-wide plummet. As of the writing of this newsletter, the following names stand as the top gainers of the week:

    Crypto

    Azit

    From among all winners of the week, the one that takes the lead by far is Azit. The Korean real estate blockchain project saw a surge in its volume on Friday, which resulted in a spectacular price explosion, taking the cryptocurrency from $0.032, straight to the $1 point. Although this peak could not be sustained, Azit is presently trading at over $0.30, reflecting a net gain of a whopping 838% climb in just a seven-day period.

    Elan

    Another name in the crypto-verse that has been performing spectacularly this last week has been Elan. The cryptocurrency undertook a week-long climb that took it from $2.50 to $7.70, in a single week. This gain translates to over 200%, with the cryptocurrency more than tripling its price during this period. The surging interest surrounding Elan traces back to last week, after its successful patent filing on its Apollo concept, offering its intellectual property protection in the market.

    GoCryptoMe

    GoCryptoMe (GCME) also proved to demonstrate a dazzling success this week in its price take-off from $0.0064 to its present price of $0.0187. This price appreciation of over 190%, coincides with epic levels of volume, presently exceeding the $22 million point. Interest around GCME has been growing since the project’s v2 platform rollout, leading to high levels of FOMO in the market.

    YFDAI.FINANCE

    YFDAI.FINANCE (YF-DAI) saw perhaps the most thrilling price trajectory of this week, resembling a rollercoaster path in many instances. On Wednesday last week, YF-DAI exploded in price, and shot up from $33.10 to a peak of $205.88. However, although this gain was short-lived, the cryptocurrency’s price, post-stabilization presently hovers around $92. Despite the price correction, therefore, YF-DAI has gained a net 179% in the prior seven days.

    hiDOODLES

    The last week saw hiDOODLES climb to mighty highs, and also fall to drastic lows. At its highest point, the cryptocurrency gained over 350%. However, in the corrections, and fightbacks that followed, hiDOODLES stands to have netted a climb of 168% during the last week, making it an impressive name on our list of top winners.

    Top Weekly Crypto Losers

    Unfortunately, given the uncertain and volatile state of the wider crypto market, there had been a lot more losers in the past week than they had been winners. Bears have been far more active, selling off their stakes and bringing the wider market capitalization lower. At the time of this writing, the following crypto-names stand as being the top weekly losers in the market:

    BITCONEY

    With its 24H trade volume of over $3 million, BITCONEY has seen a price drop of 90.8% this prior week, making it the top loser in the crypto-sphere. The mass sell-off comes after a crash in token liquidity, which immediately triggered off alarm bells, with many holdings cautioning towards a rug-pulling being underway. As its volume remains quite high, it is expected to undertake a further fall beneath its present level of $2.58.

    CryptoFi

    After its 72% price loss of the prior week, CryptoFi (CFI) has continued on this losing momentum, making it to this week’s list of losers too, having shed a further 90.7% in price. Although CFI has been gradually slipping beneath $0.000260 throughout the week, it saw a hard plummet yesterday, resulting in its present price of $0.000019. Market participants sense red flags, especially since 95% of the tokens are owned by a single address.

    Bitcoin Standard Hashrate Token

    Following signs that Bitcoin Standard Hashrate Token (BTCST) will likely be delisted from Binance, the cryptocurrency began experiencing a mass selloff due to liquidity concerns. In the process, it dropped from $5.66 to its present low of merely $1.75. This poor fall translates to a price loss of almost 70%, in a single week. Its trade volume of over $5 million further suggests that the bear is yet to calm down with BTCST

    Mithril

    Another significant name among crypto-losers this week has been Mithril (MITH), falling from $0.0127 to its present level of $0.0053, translating to a 58% drop. The hardest plummet during the week took place on Thursday, and continued its sharp fall throughout the weekend, as volume peaked at $16 million. Mithril has already seen a delisting and promises no future updates, which explains its wider unfavourability.

    Bxmi Token

    Bxmi Token has shown to be highly unpredictable over the prior week, falling suddenly to new lows without warning. It started off the week at the $0.4452 point and is presently down to $0.1802. This fall, which amounts to a weekly 60%, is likely to continue, based on the momentum seen.  Volume has gone up by 20% in the last 24 hours, and BXMI continues to hit deeper lows, as the day moves on.

  • Crypto ATH and Top Movers

    Crypto ATH and Top Movers

    Given the shift in market sentiment, as well as increased bullish activity, a number of names in the crypto-sphere have been seeing skyrocketing prices. Some have gained to such an extent, such that they have broken all prior records, and achieved all-time highs (ATH). At the time of writing this newsletter, the following names stand as being the top ATH players.

    ASAN VERSE (ASAN) was the most recent ATH winner, given its staggering takeoff, which took it to $0.0001104, earlier today. It has been on a gradual upward curve for the last ten days since it was at a low of $0.000082. This hype surrounding ASAN comes from its listing on DigiFinex, two weeks ago, and all the persistent promotion surrounding the event.

    ATH coins

    Elan

    Elan has remained largely uneventful throughout the month of November, hardly ever venturing beyond the $1.37 price. It began a gradual upward climb with the onset of December, taking it to $2.49, and then a massive price explosion in the last two days, taking it to its ATH of $5.32. This heightened interest comes after recent milestone achievements such as a worldwide patent application and the announcement of crucial partnerships.

    Fileshare Platform

    Fileshare Platform (FPC) has been seeing violent jerks in price throughout the prior month. In the last two weeks, however, its crypto price trajectory began showing a distinct upward climb, that has been taking it to new heights every day. Most recently, it raised the bar once again, taking its all-time high price to $1.72. It must be pointed out, however, that this climb comes despite any announcements about the project being released, which raises concerns about the sustainability of such a rise.

    Football Fan App

    Football Fan App (FNC) has been seeing a gradual incline in its price trend throughout the prior month, as the FIFA world cup has been progressing in Qatar. This gradual climb picked up pace in recent days, as football fever began gaining heat, with teams entering the knockout round. With France winning the semi-final against Morocco, the FNC price exploded, making it to an all-time high of $0.01157.

    Krypton DAO

    Krypton DAO (KRD), which has been in the trade since September, has been taking on an explosive price climb in recent weeks. It has not only managed to successfully sustain these epic gains but has continuously been pushing upwards too. Today it set a new ATH point by touching $1.32, a feat never achieved before. The Krypton DAO has several crypto milestone points scheduled for the upcoming weeks, which explains the growing hype surrounding it.

    Top Movers (24H)

    With bearish sentiment permeating across the market, another area where winners have been observed, in addition to ATH coins, is that of top movers. These represent those cryptocurrencies that have taken on massive climbs in price, during the last 24 hours. At the time of writing this newsletter, the top movers of the prior day are as follows:

    Strong

    Strong was the top winner of the day, considering its price rise from $4.70 to a whopping $11.60. With its trade volume at almost $4 million, which is the highest it has been today, it is evident that STRONG’s price is far from stable at present. In fact, in the last 24 hours, the cryptocurrency has seen its trade volume balloon by 1900%. This hype surrounding STRONG comes after its announced partnership with Fantom Foundation.

    YFDAI.FINANCE

    YFDAI.FINANCE saw an incredible climb during the day which took it from $52.31 to a high of $213.90. At its peak during the day, this crypto growth translated to a gain of an incredible 309%. However, as the day progressed, and the bears and the bulls continued to battle it out, these gains had leveled at 134%, bringing YFDAI.FINANCE at a stable price of $122.50. The cryptocurrency presently holds a trading volume exceeding $21 million.

    MobileCoin

    MobileCoin is also a highly noteworthy crypto name on today’s list, not necessarily due to the gain it acquired, but primarily because of its trade volume of over $60 million. At one point, MOB saw a continuous price take-off from $0.91 to $1.36, putting its rise on that point at over 49%. However, the trajectory took a more stable route throughout the day, unable to sustain the peak it had achieved. By the end of the day, MOB net gains stand at 32%.

    Christmas Doge

    Christmas Doge is another clear crypto winner from today, considering that it successfully doubled its price from $0.000010 to $0.000022, all within 24 hours. In fact, earlier during the day, XDOGE hit $0.000118, at which point its net gains amounted to 1080%. The project has just begun its journey in the secondary market, given its launch this week, and has gotten off to a hot start.

    Unicly

    Unicly (UNIC) today made it from $4.99 to an impressive high of $7.56, translating to crypto gains of almost 52%. The project has been seeing growing interest surrounding it which is evident from the rise in its trade volume, which went up from $600,000 to over $1.6 million, in 24 hours. Today’s price rise for UNIC reflects its highest gain enjoyed in over an entire month

  • Top 15 Healthcare Stocks You Should Add To Your Bucket

    The global generics drug market continues to grow with the increasing demand for more medication. Drug manufacturers are continuously striving to meet the need for more generic drugs. This industry is an opportunity-rich industry. Efficient and inexpensive drugs are often needed. The drug manufacturing industry has seen a huge transformation over the last two decades.

    This industry-main challenge is to provide the drug at lower prices than branded drugs. Drug manufacturers and Specialty Generic Industry will face more pressure in the coming years to lower the prices of drugs.  The industry is expected to grow significantly over the next decade. Check out the leading companies in drug manufacturers- specialty generic industry to see how these are addressing the needs of their customers:

    Sundial Growers Inc. (NASDAQ: SNDL)

    Sundial Growers Inc. (NASDAQ: SNDL) shares were trading down -6.32% at $0.17 at the time of writing on Wednesday. Sundial Growers Inc. (NASDAQ: SNDL) share price went from a low point around $0.17 to briefly over $4.12 in the past 52 weeks, though shares have since pulled back to $0.17. SNDL market cap has remained high, hitting $32.59M at the time of writing, giving it a price-to-sales ratio of more than 0.

    Sundial Growers Inc. (SNDL) has revealed earlier that it has expanded the Palmetto brand presence across Canada. If we look at the recent analyst rating SNDL, CIBC upgraded coverage on SNDL shares with a Neutral rating.

    Teligent Inc. (NASDAQ: TLGT)

    Teligent Inc. (NASDAQ: TLGT) last closed at $1.04, in a 52-week range of $0.65 to $8.00. The Schall Law Firm has earlier revealed that it is investigating claims on behalf of investors in Teligent, Inc. for potential breaches of fiduciary duty on the part of its directors and management. Teligent Inc.’s market cap has remained high, hitting $5.68 Million at the time of writing.

    Zomedica Corp. (AMEX: ZOM)

    Zomedica Corp. (AMEX: ZOM) stock drop by -3.82% to $0.08. Zomedica Corp. (ZOM) revealed that it has changed its legal name to Zomedica Corp. The Company’s stock trading symbol will remain as ZOM on the NYSE American and the shares will start trading under the new name effective on October 5, 2020.

    Aurora Cannabis Inc. (NYSE: ACB)

    Aurora Cannabis Inc. (NYSE: ACB) shares headed rising, higher as much as 6.36%. The most recent rating by Jefferies, on September 21, 2020, is at a Hold. Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of Aurora Cannabis Inc. (ACB) shareholders.

    Tilray Inc. (NASDAQ: TLRY)

    Tilray Inc. (NASDAQ: TLRY) rose 2.96% after gaining more than $0.19 on Wednesday. Tilray Inc. (TLRY) earlier revealed that its wholly-owned subsidiary, High Park Holdings Ltd. has introduced the newest addition to its cannabis-infused edible product line: Chowie Wowie Gummies, which are now available in select provinces across Canada.

    Neos Therapeutics Inc. (NASDAQ: NEOS)

    Neos Therapeutics Inc. (NASDAQ: NEOS) last closed at $0.86, in a 52-week range of $0.45 to $1.98. Neos Therapeutics Inc. (NEOS) has reported that its sales in quarter two reached $13.13 million. However, earnings dropped by 51.17%, resulting in a loss of $2.88 million. In Q1, Neos Therapeutics brought in $14.49 million in sales but lost $5.89 million in earnings.

    Teva Pharmaceutical Industries Limited (NYSE: TEVA)

    Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares headed rising, higher as much as 3.72%. The most recent rating by Barclays, on August 06, 2020, is at an Equal-weight. Pomerantz LLP revealed that a class action lawsuit has been lodged against Teva Pharmaceuticals Industries Limited and certain of its officers.

    Elanco Animal Health Incorporated (NYSE: ELAN)

    Elanco Animal Health Incorporated (NYSE: ELAN) shares headed falling, lower as much as -2.56%. The most recent rating by Morgan Stanley, on August 20, 2020, is at an Overweight. Elanco Animal Health Incorporated (ELAN) has revealed that it has got a notification of an unsolicited ‘mini-tender”‘ offer by TRC Capital Investment Corporation to buy up to 4,000,000 shares of Elanco common stock, representing approximately 1.00% of the outstanding shares of Elanco common stock.

    HEXO Corp. (NYSE: HEXO)

    HEXO Corp. (NYSE: HEXO) fall -0.91% after losing more than -$0.01 on Wednesday. HEXO Corp. (HEXO) has earlier disclosed that it has appointed Trent MacDonald to its executive leadership team in the acting role of Chief Financial Officer, effective October 10, 2020. Its market cap has remained high, hitting $365.78 million at the time of writing.

    Bausch Health Companies Inc. (NYSE: BHC)

    Bausch Health Companies Inc. (BHC) last closed at $17.57, in a 52-week range of $11.15 to $31.97. Analysts have a consensus price target of $26.76. Bausch Health Companies Inc. (BHC) and Lomb, its leading global eye health business, along with BHVI, revealed previously that an affiliate of Bausch Health has bought an exclusive license for a myopia control contact lens design developed by BHVI.

    Endo International plc (NASDAQ: ENDP)

    Endo International plc (NASDAQ: ENDP) stock drop by -5.69% to $5.47. The most recent rating by Goldman, on July 27, 2020, is at a Sell. Endo International plc (ENDP) revealed that it has decided to buy all of the outstanding shares of BioSpecifics Technologies Corp. for $88.50 in cash per share or an estimated enterprise value of approximately $540 million at the expected time of deal closure.

    China SXT Pharmaceuticals Inc. (NASDAQ: SXTC)

    China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) stock soar by 9.65% to $0.31. China SXT Pharmaceuticals Inc. (SXTC) share has fluctuated between the 52-weeks low of $0.22 and 52-weeks high of $1.56 during the trading session of Wednesday. It has moved up 40.64% from its 52-weeks low and moved down -79.97% from its 52-weeks high.

    Canopy Growth Corporation (NYSE: CGC)

    Canopy Growth Corporation (NYSE: CGC) rose 3.23% after gaining more than $0.61 on Wednesday. Canopy Growth Corporation (CGC) share price went from a low point around $9.00 to briefly over $25.97 in the past 52 weeks, though shares have since pulled back to $19.49. CGC market cap has remained high, hitting $7.24 billion at the time of writing.

    Aphria Inc. (NASDAQ: APHA)

    Aphria Inc. (NASDAQ: APHA) last closed at $4.68, in a 52-week range of $1.95 to $6.44. Aphria Inc. (APHA) has moved up 140.00% from its 52-weeks low and moved down -27.33% from its 52-weeks high. Its market cap has remained high, hitting $1.25 billion at the time of writing.

    China Pharma Holdings Inc. (CPHI)

    China Pharma Holdings Inc. (CPHI) stock soar by 6.86% to $0.50. The most recent rating by Rodman & Renshaw, on January 08, 2010, is at an Mkt outperform. China Pharma Holdings Inc. (CPHI) has moved up 134.13% from its 52-weeks low and moved down -64.53% from its 52-weeks high. Its market cap has remained high, hitting $22.72 million at the time of writing.

  • 15 Top Performing Stocks In Healthcare Industry

    15 Top Performing Stocks In Healthcare Industry

    The health care industry is considered to be the opportunity-rich industry. The demand in this industry is continuously increasing. Emerging technologies also play a very important role in the health care industry. Complex health and technology ecosystems and increasing consumer expectations are the major challenges which the health care industry is facing. Customers’ main priority is affordable and efficient drugs.

    If we look at the Drug manufacturers and specialty generic industry, this industry has seen a huge transformation over the last two decades. This industry is always striving to change fast enough to keep up with regulatory and patients needs. Currently, the healthcare industry has faced the major challenge of the COVID-19 pandemic. It is important to focus on what is happening in the market to increase industry growth.

    Here are the 15 leading companies in the Drug Manufacturers and specialty and generic industry:

    Zomedica Pharmaceuticals Corp. (AMEX: ZOM)

    Zomedica Pharmaceuticals Corp. (AMEX: ZOM) shares were trading up 42.86% at $0.10 at the time of writing on Monday. Zomedica Pharmaceuticals Corp. (AMEX: ZOM) share price went from a low point around $0.07 to briefly over $0.50 in past 52 weeks, though shares have since pulled back to $0.10. ZOM market cap has remained high, hitting $79.71M at the time of writing.

    Zomedica Pharmaceuticals Corp. has earlier revealed its proxy solicitor, Alliance Advisors, mailed the letter to selected shareholders in advance of its Annual and Special Virtual-Only Meeting of Shareholders. The virtual meeting is scheduled to hold on September 25, 2020.

    AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX)

    AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) last closed at $1.81, in a 52-week range of $0.70 to $2.68. AcelRx Pharmaceuticals Inc. (ACRX) announced today that the U.S. Army has granted AcelRx with an initial contract of up to approximately $3.6 million for the purchase of DSUVIA to support a study to aid the development of clinical practice guidelines. This company’s market capitalization has remained high, hitting $142.61 million at the time of writing.

    PPD Inc. (NASDAQ: PPD)

    PPD Inc. (NASDAQ: PPD) stock soar by 0.92% to $34.16. The most recent rating by KeyBanc Capital Markets, on June 04, 2020, is at an Overweight. PPD Inc. (PPD) has earlier revealed that it has received the honor of employer of choice around the world. PPD was recognized as a top 50 desirable employer in Bulgaria, according to the second annual Employer of Choice Survey organized by the employer brand and business consulting agency To The Top. This company market capitalization has remained high, hitting $11.61 billion at the time of writing.

    Adamis Pharmaceuticals Corporation (NASDAQ: ADMP)

    Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) last closed at $0.80, in a 52-week range of $0.27 to $1.51. Analysts have a consensus price target of $1.25. Adamis Pharmaceuticals Corporation (ADMP) has earlier revealed the pricing of its previously announced underwritten public offering of 16,129,032 shares of its common stock at a public offering price of $0.62 per share, resulting in gross proceeds of approximately $10,000,000.

    Rockwell Medical Inc. (NASDAQ: RMTI)

    Rockwell Medical Inc. (NASDAQ: RMTI) last closed at $1.76, in a 52-week range of $1.10 to $3.85. Rockwell Medical Inc. (RMTI) has earlier named Russell L. Skibsted, M.B.A., as Executive Vice President, Chief Financial Officer  and Chief Business Officer (CBO), effective from September 15, 2020. This company market capitalization has remained high, hitting $96.44 million at the time of writing.

    TherapeuticsMD Inc. (NASDAQ: TXMD)

    TherapeuticsMD Inc. (NASDAQ: TXMD) stock soars 2.75% to $1.44. The most recent rating by Jefferies, on August 07, 2020, is at an Underperform. TherapeuticsMD Inc. (TXMD) Knight Therapeutics Inc. and TherapeuticsMD, Inc. revealed that they received the approval of BIJUVA® (estradiol and progesterone) capsules by Health Canada. This company has a market capitalization of $368.06 million at the time of writing.

    Zoetis Inc. (NYSE: ZTS)

    Zoetis Inc. (NYSE: ZTS) rose 0.06% after gaining more than $0.01 on Tuesday. Zoetis Inc. (ZTS) has been recognized by Working Mother magazine for its career advancement opportunities, female representation and work-life programs. in the past 52-weeks of trading, Zoetis stock has fluctuated between the low of $90.14 and a high of $165.82. ZTS has moved up 78.59% from its 52-weeks low and moved down -2.92% from its 52-weeks high.  ZTS market cap has remained high, hitting $76.29 billion at the time of writing.

    DURECT Corporation (NASDAQ: DRRX)

    DURECT Corporation (NASDAQ: DRRX) stock drop by -5.41% to $1.75. The most recent rating by Oppenheimer, on July 31, 2020, is at an Outperform. DURECT Corporation (DRRX) has revealed the study design for the Phase 2b AHFIRM clinical trial of DUR-928 in severe alcoholic hepatitis (AH) patients. DURECT Corporation market cap has remained high, hitting $333.92 million at the time of writing.

    Elanco Animal Health Incorporated (NYSE: ELAN)

    Elanco Animal Health Incorporated (NYSE: ELAN) shares headed rising, higher as much as 0.56%. The most recent rating by Morgan Stanley, on August 20, 2020, is at an Overweight. In the past 52-weeks of trading, this company stock has fluctuated between the low of $15.17 and a high of 32.66. Elanco Animal Health Incorporated (ELAN) has moved up 76.01% from its 52-weeks low and moved down -18.25% from its 52-weeks high.

    Guardion Health Sciences Inc. (NASDAQ: GHSI)

    Guardion Health Sciences Inc. (NASDAQ: GHSI) rose 1.22% on Monday. Guardion Health Sciences Inc. (GHSI) share price went from a low point around $0.17 to briefly over $0.95 in the past 52 weeks, though shares have since pulled back to $0.25. Guardion Health Sciences Inc.’s market cap has remained high, hitting $22.26 million at the time of writing.

    Agile Therapeutics Inc. (NASDAQ: AGRX)

    Agile Therapeutics Inc. (NASDAQ: AGRX) shares headed falling, lower as much as -6.89%. The most recent rating by Janney, on April 12, 2019, is at a Buy. In the past 52-weeks of trading, Agile Therapeutics Inc. stock has fluctuated between the low of $0.35 and a high of $4.77. Agile Therapeutics Inc. has moved up 807.14% from its 52-weeks low and moved down -33.37% from its 52-weeks high.

    Momenta Pharmaceuticals Inc. (NASDAQ: MNTA)

    Momenta Pharmaceuticals Inc. (NASDAQ: MNTA) stock drops 0.02% after losing -0.01 on Tuesday. Momenta Pharmaceuticals Inc. (MNTA) share price went from a low point around $12.21 to briefly over $52.45 in the past 52 weeks, though shares have since pulled back to $52.36. Momenta Pharmaceuticals Inc.’s market cap has remained high, hitting $6.24 billion at the time of writing.

    Catalent Inc. (NYSE: CTLT)

    Catalent Inc. (NYSE: CTLT) stock drop 0.86% to $84.81. The most recent rating by Argus, on June 25, 2020, is at a Buy. In the past 52-weeks of trading, Catalent Inc. (CTLT) stock has fluctuated between the low of $31.04 and a high of $95.70. Catalent Inc. has moved up 173.23% from its 52-weeks low and moved down -11.38% from its 52-weeks high.  Catalent Inc. market cap has remained high, hitting $13.94 billion at the time of writing.

    Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD)

    Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD) shares headed falling, lower as much as 2.22%. The most recent rating by Northland Capital, on June 17, 2020, is at an Outperform. Ironwood Pharmaceuticals Inc. (IRWD) share price went from a low point around $7.91 to briefly over $14.10 in the past 52 weeks, though shares have since pulled back to $9.48. Ironwood Pharmaceuticals Inc.’s market cap has remained high, hitting $1.54 billion at the time of writing.

    Athenex Inc. (NASDAQ: ATNX)

    Athenex Inc. (NASDAQ: ATNX) last closed at $12.80, in a 52-week range of $5.63 to $18.35. Athenex Inc. (ATNX) has moved up 127.35% from its 52-weeks low and moved down -30.25% from its 52-weeks high.  Athenex Inc. market cap has remained high, hitting $1.14 billion at the time of writing.

  • Here’s 15 Trending Stocks In Healthcare Industry To Watch

    Here’s 15 Trending Stocks In Healthcare Industry To Watch

    The global drug manufacturers specialty & generic industry continues to grow with the increase in the demand for medication. Efficient and inexpensive drugs are the main priority of customers. Drug manufacturing is more progressive with the advent of new technologies than other areas of the pharmaceutical industry. Companies are busy in acquisitions, collaborations to increase the specialty generic capacities.

    The development of cost-effective drugs and specialty generics is a complex process.  The drug generic market has seen a huge transformation over the last few decades. Its main competitive edge is the lower prices than branded drugs. The generic industry has experienced various changes as the coronavirus pandemic takes over the world. The purchase behaviors of customers also change in 2020.

    There are various companies which are fulfilling the needs of customers in the generic industry. Here are the top 15 best players in Drug manufacturers Specialty and Generic Industry:

    Zomedica Pharmaceuticals Corp. (AMEX: ZOM)

    Zomedica Pharmaceuticals Corp. (AMEX: ZOM) shares were trading down -2.18% at $0.11 at the time of writing on Friday. Zomedica Pharmaceuticals Corp. (AMEX: ZOM) share price went from a low point around $0.10 to briefly over $0.50 in past 52 weeks, though shares have since pulled back to $0.11.

    Zomedica Pharmaceuticals Corp. (ZOM) is scheduled to present at H.C. Wainwright Virtual Global Investment Conference on September 14, 2020. Zomedica has earlier partnered with Qorvo Biotechnologies to develop three new assays Cobalamin, Canine Pancreatic Lipase, and Folate to target the diagnosis of canine gastrointestinal issues. ZOM market cap has remained high, hitting $62.09M at the time of writing.

    Teva Pharmaceutical Industries Limited (NYSE: TEVA)

    Teva Pharmaceutical Industries Limited (NYSE: TEVA) last closed at $8.79, in a 52-week range of $6.25 to $13.76. Analysts have a consensus price target of $12.19. Teva Pharmaceutical Industries Limited (TEVA) affiliate Teva Neuroscience, Inc. earlier disclosed that new study data on AUSTEDO will be presented at the International Parkinson and Movement Disorder Society annual congress (MDS Virtual Congress 2020) and during the Psych Congress 2020 Virtual Experience. Teva market cap has remained high, hitting $9.79 billion at the time of writing.

    Mylan N.V. (NASDAQ: MYL)

    Mylan N.V. (NASDAQ:; MYL) stock soar by 1.79% to $15.33. The most recent rating by SVB Leerink, on January 27, 2020, is at an Mkt perform. Mylan N.V. (MYL) has earlier bought Aspen Pharmacare Holdings Limited’s thrombosis business in Europe for €641.9 million. Mylan will pay the upfront payment of €263.2 million to Aspen. After generating cash from existing operations it will pay the €378.7 million on June 25, 2021. It has a market capitalization of $7.79 billion at the time of writing.

    Aurora Cannabis Inc. (NYSE: ACB)

    Aurora Cannabis Inc. (NYSE: ACB) last closed at $6.98, in a 52-week range of $5.30 to $78.00. Aurora Cannabis Inc. (ACB) has earlier appointed Miguel Martin its chief executive officer and also disclosed that it would book up to C$1.8 billion ($1.37 billion) in restructuring charges. It has a total market capitalization of $785.74 million at the time of writing.

    Bausch Health Companies Inc. (NYSE: BHC)

    Bausch Health Companies Inc. (NYSE: BHC) fall -1.60% after losing more than -$0.25 on Friday. Bausch Health Companies Inc. (BHC) has earlier shared its Inaugural Activity Report which showed the efforts of the Foundation from late 2017 through June 30, 2020.  Bausch Health Companies Inc. striving to improve the lives of patients globally. It has a total market cap of $5.58 billion at the time of writing.

    Endo International plc (NASDAQ: ENDP)

    Endo International plc (NASDAQ: ENDP) last closed at $2.80, in a 52-week range of $2.08 to $7.10. Endo International plc (ENDP) has earlier participated in the Citi 15th Annual BioPharma Virtual Conference being held on September 8-10, 2020. Endo International plc market cap has remained high, hitting $629.69 million at the time of writing.

    Sundial Growers Inc. (NASDAQ: SNDL)

    Sundial Growers Inc. (NASDAQ: SNDL) Shares headed falling, lower as much as -0.50%. The most recent rating by CIBC, on August 17, 2020, is at a Neutral. Sundial Growers Inc. (NASDAQ: SNDL) is scheduled to participate in
    Alliance Global Partners’ Consumer Cannabis Conference. Zachary George, Chief Executive Officer of Sundial, will take part in one-on-one sessions on September 29, 2020.

    Cronos Group Inc. (NASDAQ: CRON)

    Cronos Group Inc. (NASDAQ: CRON) fall -1.51% after losing more than -$0.08 on Friday. Cronos Group Inc. (NASDAQ: CRON) announced that its Board of Directors has named Kurt Schmidt President and Chief Executive Officer of the Company, effective September 9, 2020.  CRON also disclosed that Mike Gorenstein has been chosen as the Executive Chairman. Mike has worked as Chairman, President, and Chief Executive Officer of Cronos Group since 2016.

    Elanco Animal Health Incorporated (NYSE: ELAN)

    Elanco Animal Health Incorporated (NYSE: ELAN) last closed at $27.08, in a 52-week range of $15.17 to $32.66. Analysts have a consensus price target of $26.43. Elanco Animal Health Incorporated (NYSE: ELAN) is scheduled to participate in the Morgan Stanley 18th Annual Global Healthcare Conference on Tuesday, September 15, 2020.  Elanco Animal Health Incorporated market cap remained high, hitting $10.86 billion at the time of writing.

    Agile Therapeutics Inc. (NASDAQ: AGRX)

    Agile Therapeutics Inc. (NASDAQ: AGRX) stock soar by 2.54% to $3.63. The most recent rating by Janney, on April 12, 2019, is at a Buy. Agile Therapeutics Inc. (AGRX) is scheduled to host a virtual investor/Analyst day on Monday, September 21, 2020. It has also introduced I’m So Done, an education and empowerment platform that encourages women to think about their current contraceptive method and decision-making journey.

    Mallinckrodt plc (NYSE: MNK)

    Mallinckrodt plc (NYSE: MNK) Shares headed falling, lower as much as -7.69%. The most recent rating by JP Morgan, on May 19, 2020, is at an Underweight. Mallinckrodt plc (MNK) share price went from a low point around $1.00 to briefly over $6.42 in the past 52 weeks, though shares have since pulled back to $1.20. Mallinckrodt plc market cap has remained high, hitting $110.00 million at the time of writing.

    HEXO Corp. (NYSE: HEXO)

    HEXO Corp. (NYSE: HEXO) fall -2.82% after losing more than -$0.02 on Friday. HEXO Corp. (HEXO) share price went from a low point around $0.35 to briefly over $4.62 in the past 52 weeks, though shares have since pulled back to $0.62. HEXO Corp. market cap has remained high, hitting $331.70 million at the time of writing

    Tilray Inc. (NASDAQ: TLRY)

    Tilray Inc. (NASDAQ: TLRY) stock drop by -5.68% to $5.31. The most recent rating by The Benchmark Company, on May 12, 2020, is at a Buy. Tilray Inc. (TLRY) stock fluctuated between the 52-weeks low range of $2.43 and a high range of $32.77. It has moved up 118.52% from its 52-weeks low and moved down -83.80% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 1.80. Its market capitalization is $716.00 million.

    Momenta Pharmaceuticals Inc. (NASDAQ: MNTA)

    Momenta Pharmaceuticals Inc. (NASDAQ: MNTA) shares headed falling, lower as much as -0.12%. The most recent rating by Cowen, on August 03, 2020, is at an Outperform. Momenta Pharmaceuticals Inc. (MNTA)  share price went from a low point around $12.21 to briefly over $52.33 in the past 52 weeks, though shares have since pulled back to $52.08. Momenta Pharmaceuticals Inc. market cap has remained high, hitting $6.20 Billion at the time of writing

    Aphria Inc. (NASDAQ: APHA)

    Aphria Inc. (NASDAQ: APHA) stock drop by -2.81% to $4.50. The most recent rating by CIBC, on August 17, 2020, is at a Sector outperform. Aphria Inc. (APHA) stock fluctuated between the 52-weeks low range of $1.95 and a high range of $7.04. It has moved up 130.77% from its 52-weeks low and moved down -36.08% from its 52-weeks high. Its market capitalization is $1.20 Billion.